Submission Details
| 510(k) Number | K252352 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 29, 2025 |
| Decision Date | January 22, 2026 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K252352 is an FDA 510(k) clearance for the SMR Shoulder System; PRIMA Glenoid System; PRIMA Humeral System, a Shoulder Prosthesis, Reverse Configuration (Class II — Special Controls, product code PHX), submitted by Lima Corporate S.P.A. (Villanova Di San Daniele, IT). The FDA issued a Cleared decision on January 22, 2026, 177 days after receiving the submission on July 29, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3660.
| 510(k) Number | K252352 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 29, 2025 |
| Decision Date | January 22, 2026 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | PHX — Shoulder Prosthesis, Reverse Configuration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3660 |
| Definition | Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint. |